Ikarian Capital, LLC Hepion Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.57 - $1.22 $98,010 - $209,776	-171,948 Reduced 29.54%	410,189 $235,000
Q1 2022 May 13, 2022	BUY	$0.93 - $1.29 $26,843 - $37,234	28,864 Added 5.22%	582,137 $751,000
Q3 2021 Nov 15, 2021	SELL	$1.39 - $2.1 $1.13 Million - $1.7 Million	-811,786 Reduced 59.47%	553,273 $847,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $2.26 $2.13 Million - $3.09 Million	1,365,059 New	1,365,059 $2.7 Million

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.